Related references
Note: Only part of the references are listed.ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential Therapy
Zhaoxiang Xie et al.
INFLAMMATION (2021)
Ferroptosis-Related Gene Model to Predict Overall Survival of Ovarian Carcinoma
Liuqing Yang et al.
JOURNAL OF ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
Ting Hong et al.
REDOX BIOLOGY (2021)
Comprehensive Analysis Identifies Potential Ferroptosis-Associated mRNA Therapeutic Targets in Ovarian Cancer
Jiyan Zhang et al.
FRONTIERS IN MEDICINE (2021)
Preferences for Immunotherapy in Melanoma: A Systematic Review
Ann Livingstone et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective
Paul J. Derry et al.
PROGRESS IN NEUROBIOLOGY (2020)
Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance
Nan Liu et al.
BRITISH JOURNAL OF CANCER (2020)
PARP and PARG inhibitors in cancer treatment
Dea Slade
GENES & DEVELOPMENT (2020)
Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma Via Oxidative Stress and Iron-Sulfur Cluster Biogenesis Deficit
Wisna Novera et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury
Yingchuan Li et al.
CELL DEATH AND DIFFERENTIATION (2020)
GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling
Vanessa A. N. Kraft et al.
ACS CENTRAL SCIENCE (2020)
Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy
Qin Jiang et al.
SMALL (2020)
Dietary Lipids Induce Ferroptosis in Caenorhabditis elegans and Human Cancer Cells
Marcos A. Perez et al.
DEVELOPMENTAL CELL (2020)
Posttranslational Modifications in Ferroptosis
Xiang Wei et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Superparamagnetic Iron Oxide Nanoparticles Induce Ferroptosis of Human Ovarian Cancer Stem Cells by Weakening Cellular Autophagy
Yongyi Huang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2020)
The tumor suppressor protein p53 and the ferroptosis network
Rui Kang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Geraldine Gentric et al.
CELL METABOLISM (2019)
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion
Yang Li et al.
CELL DEATH AND DIFFERENTIATION (2019)
Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer
Fan Zhang et al.
ACS NANO (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Sulfasalazine-induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
Haochen Yu et al.
ONCOLOGY REPORTS (2019)
SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway
Xiaodan Sun et al.
FRONTIERS IN ONCOLOGY (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
Hai-Hong Zhou et al.
FRONTIERS IN ONCOLOGY (2019)
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
Lais Osmani et al.
SEMINARS IN CANCER BIOLOGY (2018)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
Eun Hye Kim et al.
CANCER LETTERS (2018)
Sideroxylin (Callistemon lanceolatus) suppressed cell proliferation and increased apoptosis in ovarian cancer cells accompanied by mitochondrial dysfunction, the generation of reactive oxygen species, and an increase of lipid peroxidation
Sunwoo Park et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Iron addiction: a novel therapeutic target in ovarian cancer
D. Basuli et al.
ONCOGENE (2017)
A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer
Mark H. Ebell et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Membranes as Structural Antioxidants RECYCLING OF MALONDIALDEHYDE TO ITS SOURCE IN OXIDATION-SENSITIVE CHLOROPLAST FATTY ACIDS
Emanuel Schmid-Siegert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE
Dmitry B. Zorov et al.
PHYSIOLOGICAL REVIEWS (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Role of Nrf2 in Oxidative Stress and Toxicity
Qiang Ma
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
ROS-Mediated Lipid Peroxidation and RES-Activated Signaling
Edward E. Farmer et al.
ANNUAL REVIEW OF PLANT BIOLOGY, VOL 64 (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DNA binding suppresses human AIF-M2 activity and provides a connection between redox chemistry, reactive oxygen species, and apoptosis
Min Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
AMID is a p53-inducible gene downregulated in tumors
M Wu et al.
ONCOGENE (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis
M Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
